Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth.
BMC Med. 2024 Feb 5;22(1):57. doi: 10.1186/s12916-024-03264-8.
BMC Med. 2024.
PMID: 38317232
Free PMC article.
Development and Validation of a Prognostic Risk Model Based on Nature Killer Cells for Serous Ovarian Cancer.
Zhang C, Qin C, Lin Y.
Zhang C, et al.
J Pers Med. 2023 Feb 24;13(3):403. doi: 10.3390/jpm13030403.
J Pers Med. 2023.
PMID: 36983585
Free PMC article.
To conclude, this study introduced a novel prognostic risk model based on NK-cell DEGs, which might provide assistance for the personalized management of serous ovarian cancer patients....
To conclude, this study introduced a novel prognostic risk model based on NK-cell DEGs, which might provide assistance for the personalized …
Item in Clipboard
Cite
Cite